Back to portfolio


Zilia's revolutionary technology platform addresses an unmet clinical need: the early assessment of biomarkers related to eye diseases, all to preserve the vision of millions of people.
Combining imaging, spectrometry and artificial intelligence, Zilia's unique technology gathers a whole new type of clinical data, paving the way for a multitude of future applications ranging from neurology and cardiology to oncology and critical care.


Sector of activity

  • Health